Cargando...
Treatment of COVID‐19 with pentoxifylline: Could it be a potential adjuvant therapy?
The world is facing a viral pandemic of a new coronavirus called COVID‐19. Pentoxifylline is a methyl‐xanthine derivative and it inhibits the phosphodiesterase IV (PDE IV). This drug is known for its unique features as an immunomodulatory and anti‐inflammatory agent, also it could have antiviral aff...
Gardado en:
| Publicado en: | Dermatol Ther |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300917/ https://ncbi.nlm.nih.gov/pubmed/32473070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.13733 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|